Tyra Biosciences grants RSUs and options to VP
Tyra Biosciences, Inc. reported that Vice President, Finance (PAO) Yuliya Rueb received equity compensation on May 5, 2026.
Rhea-AI Filing Summary
Tyra Biosciences, Inc. reported that Vice President, Finance (PAO) Yuliya Rueb received equity compensation on May 5, 2026. She was granted 8,333 restricted stock units (RSUs), each representing one share of common stock, with 1/4 of the RSUs vesting on each of the first four anniversaries of May 5, 2026, subject to continued service. Following this grant, she holds 43,354 shares of common stock directly, including RSUs. She was also granted a stock option for 28,000 shares of common stock at an exercise price of $33.93 per share, expiring on May 4, 2036, with 1/48 of the option shares vesting monthly after May 5, 2026, as long as she remains in service.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 36,333 shares
Grant/Award
2 txns
Insider
Rueb Yuliya
Role
Vice President, Finance (PAO)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 28,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 8,333 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 28,000 contracts (Direct);
Common Stock — 43,354 shares (Direct)
Footnotes (3)
- F1. Represents restricted stock units ("RSUs") granted on May 5, 2026. 1/4 of the total number of RSUs granted vest on each of the first four anniversaries of May 5, 2026, the vesting commencement date, subject to the Reporting Person's continuous service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- F2. Includes RSUs.
- F3. 1/48th of the shares subject to the option vest monthly following May 5, 2026, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
Key Figures
RSUs granted: 8,333 RSUs
Common stock holdings: 43,354 shares
Options granted: 28,000 shares
+4 more
7 metrics
RSUs granted
8,333 RSUs
Restricted stock units granted on May 5, 2026
Common stock holdings
43,354 shares
Total common shares held directly after RSU grant, including RSUs
Options granted
28,000 shares
Stock option (right to buy) granted on May 5, 2026
Option exercise price
$33.93 per share
Exercise price for the 28,000-share stock option
Option expiration
May 4, 2036
Expiration date of the stock option grant
RSU vesting schedule
1/4 annually over 4 years
RSUs vest each year on anniversaries of May 5, 2026
Option vesting schedule
1/48 monthly
Option vests monthly after May 5, 2026
Key Terms
restricted stock units ("RSUs"), Stock Option (Right to Buy), vesting commencement date, exercise price, +1 more
5 terms
restricted stock units ("RSUs") financial
"Represents restricted stock units ("RSUs") granted on May 5, 2026."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with underlying security titled Common Stock."
vesting commencement date financial
"vest on each of the first four anniversaries of May 5, 2026, the vesting commencement date"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
exercise price financial
"conversion_or_exercise_price": "33.9300""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date": "2036-05-04T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What equity awards did TYRA grant to Yuliya Rueb in this Form 4?
Tyra Biosciences granted Yuliya Rueb 8,333 RSUs and a 28,000-share stock option. The RSUs convert into common stock as they vest, while the option allows her to buy shares at a fixed $33.93 exercise price through 2036, subject to vesting.
How do the new RSUs for TYRA’s Yuliya Rueb vest over time?
The 8,333 RSUs vest in four equal annual installments. One-quarter of the RSUs vests on each of the first four anniversaries of May 5, 2026, provided Yuliya Rueb continues serving Tyra Biosciences through each vesting date.
Is the Form 4 for TYRA showing a stock purchase or compensation grant?
The Form 4 reflects compensation grants, not an open-market stock purchase. Both the 8,333 RSUs and 28,000-share stock option were awarded with a transaction code “A,” indicating grants or other acquisitions rather than a buy on the public market.
AI-generated analysis. How Rhea-AI works. Not financial advice.
